Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization.

Burixafor hydrobromide mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction [2].

1191450-19-7

C27H51N8O3P.5/2HBr

769.01

TG-0054 hydrobromide

H2O:50 mg/mL (65.02 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years